Re-analysis of Clinical Features of 89 Patients with Autoimmune Hepatitis Using the Revised Scoring System Proposed by the International Autoimmune Hepatitis Group

Objective The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was performed to assess the impact of the revised scoring system on the diagnosis of AIH. Patients and Methods We re-analyzed the clinical features of 89...

Full description

Saved in:
Bibliographic Details
Published inInternal Medicine Vol. 39; no. 12; pp. 1008 - 1012
Main Authors OMAGARIU, Katsuhisa, MASUDA, Jun-ichi, KATO, Yuji, NAKATA, Keisuke, KANEMATSU, Takashi, KUSUMOTO, Yukio, MORI, Iwao, FURUKAWA, Ryuji, TANIOKA, Hajime, TAJIMA, Heiichiro, KOGA, Michiaki, YANO, Michitami, KOHNO, Shigeru
Format Journal Article
LanguageEnglish
Published Tokyo The Japanese Society of Internal Medicine 01.12.2000
Japanese Society of Internal Medicine
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Objective The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was performed to assess the impact of the revised scoring system on the diagnosis of AIH. Patients and Methods We re-analyzed the clinical features of 89 patients diagnosed as AIH in Nagasaki Prefecture, Japan, using the revised scoring system, and compared the scores and final diagnosis with our previously published results using the original system. Results Of the 89 patients with AIH, 40 (45%) were classified using the new system as "definite" AIH, 41 (46%) as "probable" AIH, and 8 (9%) patients were categorized as "others". Of these, 37 (42%), 35 (39%), and 4 (4%) patients who were classified as "definite", "probable", and "others" by the original system remained in the same category by the revised system, respectively. However, 3, 4, and 6 patients were re-categorized as "definite" from "probable", "others" from "probable", and "probable" from "definite", respectively. The difference in aggregate scores between the above two systems ranged from -5 to +2. The main contributing factors to the changes in aggregate AIH score were "other autoimmune disease(s)" and "interface hepatitis without lobular involvement and bridging necrosis on liver histology". However, the main contributing factors to the demotions from "definite" to "probable" and form "probable" to "others" were those related to the characteristics of biliary diseases, i.e., antimitochondrial antibody positive, biliary changes in liver histology, and alkaline phosphatase: aspartate aminotransferase ratio between 1.5 and 3.0. Moreover, two patients who had no histological evidence of AIH were both re-categorized as "others" from "probable" AIH. Conclusion Our results indicated that the diagnosis, whether based on the revised or original system, was the same in the majority of AIH patients, but the revised scoring system excluded cases who had features suggestive of biliary diseases from "definite" AIH, and also confirmed that a diagnosis of "definite" AIH should not be made without liver histology. (Internal Medicine 39: 1008-1012, 2000)
AbstractList The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was performed to assess the impact of the revised scoring system on the diagnosis of AIH. We re-analyzed the clinical features of 89 patients diagnosed as AIH in Nagasaki Prefecture, Japan, using the revised scoring system, and compared the scores and final diagnosis with our previously published results using the original system. Of the 89 patients with AIH, 40 (45%) were classified using the new system as "definite" AIH, 41 (46%) as "probable" AIH, and 8 (9%) patients were categorized as "others". Of these, 37 (42%), 35 (39%), and 4 (4%) patients who were classified as "definite", "probable", and "others" by the original system remained in the same category by the revised system, respectively. However, 3, 4, and 6 patients were re-categorized as "definite" from "probable", "others" from "probable", and "probable" from "definite", respectively. The difference in aggregate scores between the above two systems ranged from -5 to +2. The main contributing factors to the changes in aggregate AIH score were "other autoimmune disease(s)" and "interface hepatitis without lobular involvement and bridging necrosis on liver histology". However, the main contributing factors to the demotions from "definite" to "probable" and form "probable" to "others" were those related to the characteristics of biliary diseases, i.e., antimitochondrial antibody positive, biliary changes in liver histology, and alkaline phosphatase: aspartate aminotransferase ratio between 1.5 and 3.0. Moreover, two patients who had no histological evidence of AIH were both re-categorized as "others" from "probable" AIH. Our results indicated that the diagnosis, whether based on the revised or original system, was the same in the majority of AIH patients, but the revised scoring system excluded cases who had features suggestive of biliary diseases from "definite" AIH, and also confirmed that a diagnosis of "definite" AIH should not be made without liver histology.
Objective The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was performed to assess the impact of the revised scoring system on the diagnosis of AIH. Patients and Methods We re-analyzed the clinical features of 89 patients diagnosed as AIH in Nagasaki Prefecture, Japan, using the revised scoring system, and compared the scores and final diagnosis with our previously published results using the original system. Results Of the 89 patients with AIH, 40 (45%) were classified using the new system as "definite" AIH, 41 (46%) as "probable" AIH, and 8 (9%) patients were categorized as "others". Of these, 37 (42%), 35 (39%), and 4 (4%) patients who were classified as "definite", "probable", and "others" by the original system remained in the same category by the revised system, respectively. However, 3, 4, and 6 patients were re-categorized as "definite" from "probable", "others" from "probable", and "probable" from "definite", respectively. The difference in aggregate scores between the above two systems ranged from -5 to +2. The main contributing factors to the changes in aggregate AIH score were "other autoimmune disease(s)" and "interface hepatitis without lobular involvement and bridging necrosis on liver histology". However, the main contributing factors to the demotions from "definite" to "probable" and form "probable" to "others" were those related to the characteristics of biliary diseases, i.e., antimitochondrial antibody positive, biliary changes in liver histology, and alkaline phosphatase: aspartate aminotransferase ratio between 1.5 and 3.0. Moreover, two patients who had no histological evidence of AIH were both re-categorized as "others" from "probable" AIH. Conclusion Our results indicated that the diagnosis, whether based on the revised or original system, was the same in the majority of AIH patients, but the revised scoring system excluded cases who had features suggestive of biliary diseases from "definite" AIH, and also confirmed that a diagnosis of "definite" AIH should not be made without liver histology. (Internal Medicine 39: 1008-1012, 2000)
Author KANEMATSU, Takashi
KOGA, Michiaki
KOHNO, Shigeru
KUSUMOTO, Yukio
OMAGARIU, Katsuhisa
NAKATA, Keisuke
MASUDA, Jun-ichi
FURUKAWA, Ryuji
KATO, Yuji
YANO, Michitami
TAJIMA, Heiichiro
TANIOKA, Hajime
MORI, Iwao
Author_xml – sequence: 1
  fullname: OMAGARIU, Katsuhisa
  organization: the Second Department of Internal Medicine, Nagasaki University School of Medicine
– sequence: 2
  fullname: MASUDA, Jun-ichi
  organization: the Second Department of Internal Medicine, Nagasaki University School of Medicine
– sequence: 3
  fullname: KATO, Yuji
  organization: the First Department of Internal Medicine, Nagasaki University School of Medicine
– sequence: 4
  fullname: NAKATA, Keisuke
  organization: the First Department of Internal Medicine, Nagasaki University School of Medicine
– sequence: 5
  fullname: KANEMATSU, Takashi
  organization: the Second Department of Surgery, Nagasaki University School of Medicine
– sequence: 6
  fullname: KUSUMOTO, Yukio
  organization: Department of Internal Medicine, Nagasaki City Hospital
– sequence: 7
  fullname: MORI, Iwao
  organization: Department of Internal Medicine, Nagasaki City Hospital
– sequence: 8
  fullname: FURUKAWA, Ryuji
  organization: Department of Internal Medicine, Nagasaki Red Cross Atomic Bomb Hospital
– sequence: 9
  fullname: TANIOKA, Hajime
  organization: Department of Internal Medicine, Sasebo Municipal General Hospital
– sequence: 10
  fullname: TAJIMA, Heiichiro
  organization: Department of Internal Medicine, Nagasaki Rousai Hospital
– sequence: 11
  fullname: KOGA, Michiaki
  organization: Institute for Clinical Research, Nagasaki Chuo National Hospital
– sequence: 12
  fullname: YANO, Michitami
  organization: Institute for Clinical Research, Nagasaki Chuo National Hospital
– sequence: 13
  fullname: KOHNO, Shigeru
  organization: the Second Department of Internal Medicine, Nagasaki University School of Medicine
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=903755$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/11197782$$D View this record in MEDLINE/PubMed
BookMark eNptkN1q3DAQhUVJaTZpX6EIeu2tZa0s6TIszQ8EGrLNtRnL46yCLRtJbtnn6YtW3t1uIO3NCOZ8Z2Z0LsiZGxwSQlm-LFipv1oX0TvoemyssQ6XXC9Znqt3ZMH4Smey4OKMLHLNVFakck4uQnjJc66kLj6Qc8aYllIVC_L7ETNIk3bBBjq0dN1ZZw109BohTh73TaXpA0SLLgb6y8YtvZriYPt-ckhvcUxSTO6nYN0zjVukj_jTBmzoxgx-7m12IWJPH_wwDnO_3u2xu8Mvoh3SAf-feeOHafxI3rfQBfx0fC_J0_W3H-vb7P77zd366j4zQoiYNUZxbTSsyhKUbqCUsjUrpUULRut6xU3RSoOgGlEyUzAmmlLVDLippVBc8UuiDnONH0Lw2Fajtz34XcXyas69ept7xXU1556snw_WcaqT-Go8Bp2AL0cAQoq39eCMDSdO51wKkajNgXoJEZ7xJIOP1nT4z36mdbG_4W-djznRZgu-Qsf_AFpDtHY
CitedBy_id crossref_primary_10_1002_hep_22322
crossref_primary_10_1007_s40266_018_0556_0
crossref_primary_10_1097_00001574_200205000_00007
crossref_primary_10_1097_00042737_200406000_00012
crossref_primary_10_3390_diagnostics14020210
crossref_primary_10_1016_j_jhep_2010_06_032
crossref_primary_10_3892_etm_2013_1366
crossref_primary_10_1586_eem_09_6
crossref_primary_10_3390_biology12030479
crossref_primary_10_1053_jhep_2002_34944
crossref_primary_10_33590_emjhepatol_10313935
ContentType Journal Article
Copyright The Japanese Society of Internal Medicine
2001 INIST-CNRS
Copyright_xml – notice: The Japanese Society of Internal Medicine
– notice: 2001 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.2169/internalmedicine.39.1008
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1349-7235
EndPage 1012
ExternalDocumentID 10_2169_internalmedicine_39_1008
11197782
903755
article_internalmedicine1992_39_12_39_12_1008_article_char_en
Genre Validation Studies
Comparative Study
Review
Journal Article
GeographicLocations Asia
Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
.55
29J
2WC
3O-
53G
5GY
7.U
AAPBV
AAUGY
ACPRK
ADBBV
ADRAZ
AENEX
AFRAH
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
CS3
DIK
DU5
EBS
EJD
EMOBN
F5P
HYE
JSF
JSH
M48
M~E
OK1
P2P
RJT
RNS
RPM
RZJ
TKC
TR2
X7M
XSB
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
PGMZT
AAYXX
CITATION
ID FETCH-LOGICAL-c555t-dc839c9a466a89da677fc4895fac99b43c2f7cea8d561c2115d68b1a3cb758383
ISSN 0918-2918
IngestDate Fri Aug 23 04:02:21 EDT 2024
Sat Sep 28 08:40:35 EDT 2024
Sun Oct 29 17:06:44 EDT 2023
Thu Aug 17 20:27:40 EDT 2023
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 12
Keywords Autoimmunity
Human
Hepatitis
Liver
Digestive diseases
Hepatic disease
Histology
Serology
Diagnosis
Language English
License CC BY 4.0
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c555t-dc839c9a466a89da677fc4895fac99b43c2f7cea8d561c2115d68b1a3cb758383
OpenAccessLink https://www.jstage.jst.go.jp/article/internalmedicine1992/39/12/39_12_1008/_article/-char/en
PMID 11197782
PageCount 5
ParticipantIDs crossref_primary_10_2169_internalmedicine_39_1008
pubmed_primary_11197782
pascalfrancis_primary_903755
jstage_primary_article_internalmedicine1992_39_12_39_12_1008_article_char_en
PublicationCentury 2000
PublicationDate 2000-12-01
PublicationDateYYYYMMDD 2000-12-01
PublicationDate_xml – month: 12
  year: 2000
  text: 2000-12-01
  day: 01
PublicationDecade 2000
PublicationPlace Tokyo
PublicationPlace_xml – name: Tokyo
– name: Japan
PublicationTitle Internal Medicine
PublicationTitleAlternate Intern. Med.
PublicationYear 2000
Publisher The Japanese Society of Internal Medicine
Japanese Society of Internal Medicine
Publisher_xml – name: The Japanese Society of Internal Medicine
– name: Japanese Society of Internal Medicine
References 1) Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 18: 998-1005, 1993.
11) McFarlane IG. The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis. Gut 42:599-602, 1998.
5) Gordon SC. Diagnostic criteria, clinical manifestations and natural history of autoimmune hepatitis, in: Autoimmune Liver Diseases. 2nd ed. Krawitt EL, Wiesner RH, Nishioka M, Eds. Elsevier, Amsterdam, 1998: 343-360.
9) McNair ANB, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol 93: 777-784, 1998.
2) Omagari K, Kinoshita H, Kato Y, et al. Clinical features of 89 patients with autoimmune hepatitis in Nagasaki Prefecture, Japan. J Gastroenterol 34: 221-226, 1999.
4) Toda G, Zeniya M, Watanabe F, et al. Present status of autoimmune hepatitis in Japan-Correlating the characteristics with international criteria in an area with a high rate of HCV infection. J Hepatol 26: 1207-1212, 1997.
7) Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 125:588-598, 1996.
3) International Autoimmune Hepatitis Group Report. Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31: 929-938, 1999.
6) Toda G. Interferon or corticosteroid: Treatment of patients with chronic hepatitis C positive for serum markers of autoimmune diseases. Intern Med 36: 233-235, 1997.
8) Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. Hepatology 28: 360-365, 1998.
10) Mackay IR. Autoimmune disease overlaps and the liver: Two for the price of one? J Gastroenterol Hepatol 15: 3-8, 2000.
12) Mackay IR, Davies JM, Rowley MJ. Towards the pathogenesis of autoimmune liver disease. J Autoimmun 13: 163-169, 1999.
11197810 - Intern Med. 2000 Dec;39(12):999-1000
References_xml
SSID ssj0038792
Score 1.6796536
SecondaryResourceType review_article
Snippet Objective The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was...
The diagnostic criteria of autoimmune hepatitis (AIH) were recently modified by the International Autoimmune Hepatitis Group. This study was performed to...
SourceID crossref
pubmed
pascalfrancis
jstage
SourceType Aggregation Database
Index Database
Publisher
StartPage 1008
SubjectTerms Adult
Aged
Alanine Transaminase - blood
Alcohol Drinking - epidemiology
Alkaline Phosphatase - blood
Antibodies, Antinuclear - blood
Antibody Specificity
Aspartate Aminotransferases - blood
Autoantibodies - blood
Autoantibodies - immunology
Autoimmune Diseases - diagnosis
Autoimmune Diseases - epidemiology
Autoimmune Diseases - genetics
Autoimmune Diseases - immunology
Autoimmune Diseases - pathology
autoimmune hepatitis
Bile Ducts - pathology
Biological and medical sciences
Diagnosis, Differential
Female
Gastroenterology. Liver. Pancreas. Abdomen
Genetic Predisposition to Disease
Genotype
Hepatitis, Autoimmune - diagnosis
Hepatitis, Autoimmune - epidemiology
Hepatitis, Autoimmune - genetics
Hepatitis, Autoimmune - immunology
Hepatitis, Autoimmune - pathology
Hepatitis, Viral, Human - diagnosis
HLA-DR Antigens - analysis
HLA-DR Antigens - genetics
Humans
Japan - epidemiology
Liver Diseases, Alcoholic - diagnosis
Liver. Biliary tract. Portal circulation. Exocrine pancreas
Male
Medical sciences
Middle Aged
Mitochondria, Liver - immunology
Other diseases. Semiology
Retrospective Studies
revised international AIH scoring system
Title Re-analysis of Clinical Features of 89 Patients with Autoimmune Hepatitis Using the Revised Scoring System Proposed by the International Autoimmune Hepatitis Group
URI https://www.jstage.jst.go.jp/article/internalmedicine1992/39/12/39_12_1008/_article/-char/en
https://www.ncbi.nlm.nih.gov/pubmed/11197782
Volume 39
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Internal Medicine, 2000, Vol.39(12), pp.1008-1012
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1ba9swFBZtN8ZgjN2XLRt62Ku7-iJbejTdpd2WFkoCfTOyLFNnkITaftj-zv7ozpEsO0kz2O1FBGGJY74vR0fyd44IecOL2C8Ujzwe5EdeJHLmifCo8FikJfPLWOcSzyEnZ_HJLPp0yS739sdrqqW2yQ_V9515JX-DKvQBrpgl-wfI9pNCB_wGfKEFhKH9LYwvtCfXioocuyxHjOvaa1tOlgssw18NiWxp2ywrzArRsOagnrqB0VY5gEEofiyoMQpVVppnS5pjQsFqWXfhai-4dCeJO-ccjrXmg1zeRL-TrQ_655P0Y3pxOuvkHXV7VdX9cjEBz_8utRkkC69SV1W_SKTTc7OEtPO-7yyF3tRmHFV1-1VvHGtsS0RMYhyEC3gNZy9g7ZJrblranWj6mFDSuXNt_XkYCS8JbEUU5_Bt9SRH7GDNfWOlo7VQAGuf7VpmAj_GKq1VZ4tTQRwCQ4cZNop4dxTJtoeg-DcLRea7Fsdn7mlMvAOe75NbAbhRI0I4_ezijJAn5srv_rWtTg1te_sryzaCr9tz2H9gYYl7K1kDOUt7k8vW_srEWdMH5H63QaKpNe4h2dOLR-SOw-Ex-bFGerosqSM9daTHTi6oIz1F0tOBoLQnKDWkp8Bm2pGedqSnlvTUkZ7m38xjG6TfPach_RMy-_B-enzidTeNeIox1njgrUKhhIziWHJRyDhJShVxwUqphMijUAVlorTkBWw3VAC7qCLmuS9DlSeoOwifkoPFcqGfExqUZRGGEYTOgkUlhMOFDoRiMsw152WQjIjvIMhWtqAMgJ4hbDfYYTgBsI3IF4tVP-Kf-DQi4w3E-1kFXojNRuSZJcBgH2oNYCvx4v_a8ZLcHf75Y3LQXLf6FYT4Tf7aMP0n8mMLMw
link.rule.ids 315,783,787,27936,27937
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Re-analysis+of+Clinical+Features+of+89+Patients+with+Autoimmune+Hepatitis+Using+the+Revised+Scoring+System+Proposed+by+the+International+Autoimmune+Hepatitis+Group&rft.jtitle=Internal+Medicine&rft.au=OMAGARIU%2C+Katsuhisa&rft.au=MASUDA%2C+Jun-ichi&rft.au=KATO%2C+Yuji&rft.au=NAKATA%2C+Keisuke&rft.date=2000-12-01&rft.pub=The+Japanese+Society+of+Internal+Medicine&rft.issn=0918-2918&rft.eissn=1349-7235&rft.volume=39&rft.issue=12&rft.spage=1008&rft.epage=1012&rft_id=info:doi/10.2169%2Finternalmedicine.39.1008&rft.externalDocID=article_internalmedicine1992_39_12_39_12_1008_article_char_en
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0918-2918&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0918-2918&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0918-2918&client=summon